Phenotype and Genotype Frequency of β-Thalassemia and Sickle Cell Disease Carriers in Halkidiki, Northern Greece
Christoforos Kalleas, Ioannis Tentes(Democritus University of Thrace), Klio Sinopoulou(Laiko General Hospital of Athens), Kostas Anagnostopoulos(Democritus University of Thrace), Constantinos Tsatalas(Democritus University of Thrace), Alexandros X. Kortsaris(Democritus University of Thrace), Dimitrios Margaritis(Democritus University of Thrace), Evangelia Delaki(Laiko General Hospital of Athens), Georgios Bourikas(Democritus University of Thrace)
Cited by 8
Related Papers
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
|Journal of Clinical Oncology|2007|279
Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
|Leukemia & lymphoma/Leukemia and lymphoma|2006|160
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
|Leukemia Research|2010|63
Plerixafor+G-CSF–mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy
|Blood|2015|49
Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent era
|European Journal Of Haematology|2012|37